Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Qiang Tao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7289-9778; OpenAlex author ID A5102831649. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 7

  1. Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Report. Co-author DOI 10.1002/cnr2.70547↗
  2. Retraction notice to "Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and IT… Co-author DOI 10.1016/j.ijbiomac.2026.153659↗
  3. Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study. Co-author DOI 10.3389/fimmu.2026.1841783↗
  4. Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant protei… Co-author DOI 10.1016/j.ijbiomac.2024.139078↗
  5. Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study. First author DOI 10.21037/atm-22-2217↗
  6. circPUM1 Activates the PI3K/AKT Signaling Pathway by Sponging to Promote the Proliferation, Invasion and Glycolysis of Pancreatic Cancer. Co-author DOI 10.2174/1389201022666210713152457↗
  7. UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression. Co-author DOI 10.1007/s12094-021-02565-1↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjie Shi · 2 shared papers, 2025–2026 · strength 0.56
  2. Guangquan Zhang · 2 shared papers, 2025–2026 · strength 0.56
  3. Lingmin Jiang · 2 shared papers, 2022–2026 · strength 0.44
  4. Songlin Peng · 1 shared paper, 2026 · strength 0.32
  5. Chaobin He · 1 shared paper, 2026 · strength 0.32
  6. Shengping Li · 1 shared paper, 2026 · strength 0.32
  7. Kaiwen Zhong · 1 shared paper, 2026 · strength 0.32
  8. Pu Xi · 1 shared paper, 2026 · strength 0.32
  9. Youwen Fan · 2 shared papers, 2021–2022 · strength 0.30
  10. Fei Huang · 1 shared paper, 2022 · strength 0.16
  11. Dong Li · 1 shared paper, 2022 · strength 0.16
  12. Di Tang · 1 shared paper, 2021 · strength 0.14
  13. Chao Ma · 1 shared paper, 2021 · strength 0.14
  14. Yun Zheng · 1 shared paper, 2022 · strength 0.13
  15. Andreas Minh Luu · 1 shared paper, 2022 · strength 0.13
  16. Zhiwen Yang · 1 shared paper, 2022 · strength 0.13
  17. Yong Wang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.